Optimal Brain Oxygenation in Neurologic Intensive Care Unit : The NeurO2 Study

UnknownOBSERVATIONAL
Enrollment

286

Participants

Timeline

Start Date

May 7, 2021

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2025

Conditions
Traumatic Brain InjurySubarachnoid HemorrhageBrain InjuriesNear-Infrared SpectroscopyIntensive Care Neurological DisorderAnemia
Interventions
OTHER

Near-infrared spectroscopy (NIRS)

Non invasive brain oxygenation monitoring with Near-Infrared Spectroscopy (NIRS) technology. Patients enrolled in the NeurO2 study will have bilateral NIRS sensors applied to the forehead according to manufacturer recommendations. Data will be monitored continuously throughout the study intervention in the parent trials (HEMOTION and SAHaRA trials) in the neurocritical care unit. Data will be extracted from the device at the end of the study period.

Trial Locations (2)

Unknown

RECRUITING

The Ottawa Hospital, Ottawa

G1J-1Z4

RECRUITING

CHU de Québec - Université Laval (Hôpital de l'Enfant-Jésus), Québec

Sponsors
All Listed Sponsors
collaborator

Ottawa Hospital Research Institute

OTHER

collaborator

Canadian Critical Care Trials Group

OTHER

collaborator

Canadian Traumatic Brain Injury Research Consortium

UNKNOWN

lead

CHU de Quebec-Universite Laval

OTHER